General contact

Head Office
Novartis International AG
CH-4002 Basel

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)


Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel

+41 61 324 79 44


Global Oncology Media Relations
Denise Brashear
Novartis Oncology Global Public Relations

+1 862 778 7336

Novartis Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

pane 4 content

This site is not intended for U.S. residents.

Open Partnerships

Collaboration leads to breakthroughs

There is power in collaboration. More than a decade of success in helping people living with cancer has taught us the value of connections within the oncology community and their importance to innovation. The recent acquisition of the GSK oncology portfolio opens new potential for collaborations that may lead to the development of breakthrough therapies to transform patients’ lives.

We realize the vital power of connections every day:

  • Relationships within the oncology care community enable us to conduct high-quality clinical trials with competitive timelines and aid in the discovery and development of new medicines and indications to benefit patients.
  • Patient groups and advocates help us better understand patient needs and barriers to treatment success.
  • Health authorities help us to speed delivery of new treatments for patients through ongoing dialogue and innovative approaches to regulatory review and approval.
  • Biotech partners complement our research and development strategy, from basic research through commercialization.
  • Payers help us improve availability of new therapies to patients most likely to achieve results.

"The power of collaboration brings innovation to life".